Abstract
purpose. To study patterns of expression of alternatively spliced tenascin-C
(TN-C) variants believed to mediate cellular activities in human
corneal development.
methods. Serial sections of preterm, neonatal, child, and adult globes with
normal anterior segments were labeled with monoclonal antibodies to
TN-C. The antibodies included BC-4 and BC-8, which recognize epitopes
in conserved domains of TN-C and can thus detect all TN-C variants, and
BC-2, α-A2, α-A3, α-IIIB, TN11, and α-D, which bind to epitopes
in alternatively spliced fibronectin type III repeats of TN-C. Bound
antibodies were localized and visualized using an avidin-biotin
complex–alkaline phosphatase technique.
results. BC-4 and BC-8 showed similar patterns of staining, widely observed in
preterm corneas, less so in neonatal corneas, and restricted to the
limbus in the child and adult. BC-2, α-A2, α-A3, α-IIIB, TN11,
and α-D staining was largely localized in corneal epithelium (preterm
and neonatal), limbal epithelium, mast cells, and matrix surrounding
limbal vessels (preterm, neonatal, child, and adult).
conclusions. TN-C may play a role in corneal development and in growth and
differentiation of stem cells because it is widely expressed in the
preterm cornea, less so in the neonate, and is restricted to the limbus
in the child and adult. The differential patterns of expression of TN-C
variants in normal corneas (preterm and neonatal), and in the limbus
(preterm, neonatal, child, and adult), suggest specific roles played by
each variant, and cell type–specific expression of the different
variants.
Tenascin-C (TN-C) is a matricellular protein
1 believed to play important roles in tissue development, wound healing,
and repair, because it mediates several cellular activities including
cell adhesion and antiadhesion, migration, proliferation, and
differentiation (reviewed by Chiquet–Eherismann et al. and
Mackie
2 3 ). In humans, TN-C is encoded by a single gene
localized within region q32-q34 of chromosome nine,
4 5 and
thus the expression of a single protein would be expected. This is,
however, not the case, because TN-C mRNA undergoes alternative splicing
(Fig. 1) , generating variants that incorporate all (high
M
r variants), some (intermediate
M
r variants), or none (low
M
r variants) of the fibronectin type III repeats,
TNCfn-A1 to TNCfn-D.
6 7 8 9 10 11 12 13
The expression of alternatively spliced variants with different
compositions of the TNCfn repeats, in part, explains the pleiotropic
nature of TN-C. Functional studies have, to some extent, identified
specific repeats that mediate cell antiadhesion (TNCfn-1 to -4 and
TNCfn-A1 to -A4), migration (TNCfn-10 and TNCfn-11), and growth and
differentiation (TNCfn-A2, TNCfn-A3, TNCfn-5, TNCfn-6, TNCfn-B,
and TNCfn-D).
6 7 14 15 16 17 18 19 20 21 22 23
The expression of TN-C in the normal adult human cornea, in healing and
repair, and in pathologic human corneas has been described in our
previous studies
24 25 26 and by other
researchers.
13 27 28 29 30 31 More recently, adult human corneas
including normal corneas, those with wound healing and scarring, and
corneas from cases of bullous keratopathy have been investigated for
the presence of alternatively spliced TN-C mRNA
12 13 and
the expression of TN-C variants.
13 25 26 However, there
are currently few data regarding the patterns of expression of the TN-C
variants during development of the human cornea. Therefore, it was
envisaged that unraveling any differences in patterns of expression of
TN-C variants in relation to human corneal development might enable a
better understanding of the role of this glycoprotein in determining
corneal morphology and development.
Using a light microscope (BH2; Olympus, Tokyo, Japan) equipped
with a camera (C-35AD-4; Olympus), we examined serial sections from
each of the specimens for IHC staining achieved with each of the mAbs.
By exciting the substrate (Vector red) reaction product using a
rhodamine filter system (535–560 nm), localized antibody reaction
could be visualized as a fluorescent bright red color. Black and white
micrographs were made (1600-PR film; Fuji, Tokyo, Japan) at a constant
exposure time of 1.25 minutes. Observation was also made using
transmitted light to reveal tissue and cellular morphology. For these,
black and white micrographs were made with automatic exposure (TMY 400
film; Eastman Kodak, Rochester, NY).
In this study, we stained serial sections from developing and
mature normal human corneas with eight mAbs
(Fig. 1) specific to human
TN-C. Two of these (BC-4 and BC-8) bind to epitopes in conserved
domains
8 32 and thus revealed the general patterns of TN-C
expression in these tissues
(Fig. 2) . The others bind to epitopes
localized to alternatively spliced fibronectin type III repeats
(TNCfn-A1 to D)
8 32 33 and thus revealed the patterns of
expression of TN-C variants (
Table 2 ;
Figs. 3 4 ). It was not possible
to investigate the patterns of expression of TN-C variants
incorporating repeats TNCfn-AD1 and TNCfn-AD2 because there were no
relevant antibodies. Nevertheless, this is the first study to use a
range of mAbs and serial sections to document the patterns of
expression of TN-C variants in preterm, neonate, and child as well as
in normal human adult corneas.
Results (
Table 2 ;
Figs. 2 3 4 ) indicated that TN-C was abundantly
expressed in normal preterm corneas, but less so in neonatal corneas,
and was restricted to the limbus in the child and adult. These findings
are consistent with the transient pattern of expression of TN-C which
has been described in several developing tissues such as skin, lung,
and tooth (reviewed by Chiquet–Eherismann et al. and
Mackie),
2 3 and in agreement with a role for TN-C in
corneal development previously suggested in the
chicken.
34 35
Our results also showed that there are differential patterns of
expression of TN-C variants. For example, only those containing repeats
TNCfn-A2 and TNCfn-B were detected in the preterm and neonatal corneal
stroma, whereas the epithelium and, to some extent, the endothelium of
preterm and neonatal corneas were positive for several TN-C variants
(
Table 2 ;
Figs. 3 4 ). At the limbus at all age groups examined, the
epithelium, unlike the matrix and vessels, showed presence of a number
of TN-C variants (
Table 2 ;
Figs. 3 4 ).
The expression of TN-C, but not its variants, has been described in the
epithelium of a 3-month-old fetal cornea,
27 and in the
limbus of adult corneas.
24 25 26 27 28 29 30 31 More recently, studies
using reverse transcription–polymerase chain reaction (RT-PCR) have
demonstrated the presence of TN-C mRNA isoforms in epithelium, stroma,
and endothelium of normal adult corneas.
12 13 However, in
agreement with our findings, TN-C proteins were not detected in either
of these studies. There is, as yet, no explanation for the absence of
expression of TN-C proteins in normal child and adult human
corneas.
24 25 26 27 28 29 30 31 There is (other than at the limbus)
interspecies variation in that the expression in the
mouse
36 is similar to that in humans, whereas in
the rabbit, TN-C has been immunodetected in the entire epithelium of
normal adult rabbit corneas.
37 38 39 The differential
patterns of localization in the human cornea may be important in
corneal development and in remodeling by mediating dynamic cellular
functions such as migration, proliferation, and differentiation. A
220-kDa TN-C variant was found to be associated with migrating
epithelium of developing avian cornea
34 although the
authors unfortunately did not define the composition of the
alternatively spliced repeats. Other investigations have shown that
repeats A2, A3, B, and D can mediate neurite outgrowth and neuronal
differentiation
16 19 20 21 22 23 whereas variants incorporating
repeats A2, A3, and B promote cell migration in vitro and are expressed
by migrating cells such as glia and osteoblasts.
21 22 23
A novel finding of retention of TN-C variants incorporating repeat
TNCfn-C in mast cells in the child and adult corneas studied is
probably related to the presence of vascularization at the limbus, for
mast cells are known to be associated with vessel
formation.
23 40 This may provide a favorable matrix for
mast cell–associated angiogenesis and cell proliferation as noted by
Carnemolla et al.
33
Retained expression of TN-C in the child and adult normal limbus (
Table 2 ;
Fig. 2D ) is of interest. TN-C expression is seen in normal,
continuously renewing adult tissues such as the epithelial–mesenchymal
interface of the gastrointestinal tract
2 and is
transiently expressed in the placenta and endometrium—tissues
known to exhibit dynamic cellular activity.
41 42 The
limbus is a region of high cellular activity involving proliferation
and differentiation of stem cells.
43 Thus, TN-C variants
in the limbus may provide a favorable milieu for continued corneal
epithelial replenishment and vascularization. The various TN-C variants
found in the limbus of these corneas may be due to
cell-cycle–dependent TN-C mRNA alternative
splicing.
44
In summary, this study has shown that in the normal human cornea TN-C
is widely expressed in the preterm infant, less so in the neonate, and
is restricted to the limbus in the child and adult. This pattern of
expression supports the view that TN-C plays a role in corneal
development. Retained expression of TN-C in the limbus of normal child
and adult corneas may indicate a role in the growth and differentiation
of limbal stem cells and the continuous replenishment of corneal
epithelium. Furthermore, TN-C variants are differentially expressed in
the preterm and neonatal corneal layers, and in the limbus of preterm,
neonatal, child and adult corneas. This may indicate specific roles
played by each variant and, possibly, cell type–specific expression of
the different variants at different times during development and
remodeling.
Supported by the Manchester Royal Eye Hospital Endowments.
Submitted for publication September 28, 1999; revised February 29 and July 13, 2000; accepted July 28, 2000.
Commercial relationships policy: N.
Corresponding author: Henry Maseruka, The Academic Department of Ophthalmology, Royal Eye Hospital, Oxford Road, Manchester, UK M13 9WH.
[email protected]
Table 1. Normal Corneas: Demographic, Clinical, and Pathologic Details
Table 1. Normal Corneas: Demographic, Clinical, and Pathologic Details
Cornea | Clinical and Pathologic Details |
P-1 and P-2 | Eyes obtained after death from a premature boy (24 weeks gestation). Early retinopathy of prematurity. Died 1 day later from bronchopneumonia. Normal corneas and anterior segment. |
P-3 | Eye from a stillborn girl (34 weeks gestation). Early retinoblastoma. Normal cornea and anterior segment. |
N-1 | Eye from a male neonate (5 weeks postpartum). Nonaccidental death. Normal cornea and anterior segment. |
N-2 and N-3 | Eyes from a male neonate (5 months postpartum), who was premature (27 weeks gestation) birth. On intensive care (continuous ventilatory oxygen). Died of bronchopulmonary dysplasia. Minimal retinopathy of prematurity. Normal corneas and anterior segment. |
C-1 | Eye from a male child (2 year). Enucleated for retinoblastoma. Normal cornea and anterior segment. |
C-2 | Eye from a male child (2 year). Enucleated for retinoblastoma. Normal cornea and anterior segment. |
A-1 | Eye from a 40-year-old man. Enucleated for malignant choroidal melanoma. Normal cornea and anterior segment. |
A-2 | Eye from 62-year-old man. Enucleated for malignant choroidal melanoma. Normal cornea and anterior segment. |
A-3 | Eye from a 90-year-old man. Enucleated for malignant choroidal melanoma. Normal cornea and anterior segment. |
Table 2. The Expression of TN-C Variants in the Human Cornea
Table 2. The Expression of TN-C Variants in the Human Cornea
| A1 and/or A4 | A2 | A3 | B | C | D |
Preterm | | | | | | |
Limbus | | | | | | |
Epithelium | + | + | − | + | + | + |
Vessels | − | + | − | + | + | − |
Corneal–scleral interface | − | − | − | + | − | − |
Cornea | | | | | | |
Epithelium | + | + | + | + | + | + |
Stroma | − | + | − | + | − | − |
Endothelium | + | + | + | + | + | + |
Neonate | | | | | | |
Limbus | | | | | | |
Epithelium | + | + | − | + | + | + |
Vessels | − | + | + | + | + | + |
Corneal–scleral interface | − | − | − | + | − | − |
Cornea | | | | | | |
Epithelium | + | + | + | + | + | + |
Stroma | − | + | − | + | − | − |
Endothelium | − | + | − | − | + | + |
Child/adult | | | | | | |
Limbus | | | | | | |
Epithelium | + | + | − | + | + | + |
Vessels | − | + | + | + | + | − |
Corneal–scleral interface | − | + | − | + | − | + |
Cornea | | | | | | |
Epithelium | − | − | − | − | − | − |
Stroma | − | − | − | − | − | − |
Endothelium | − | − | − | − | − | − |
The authors thank Luciano Zardi and coworkers at Centro
Biotecnologie Avanzate, Genova, Italy, for the kind gift of monoclonal
antibodies to human TN-C.
Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol
. 1995;130:503–506.
[CrossRef] [PubMed]Chiquet–Eherismann R, Hagios C, Matsumoto K. The tenascin gene family. Perspect Devel Neurobiol. 1994;2:3–7.
Mackie EJ. Molecules in focus: tenascin-C. Int J Biochem Cell Biol
. 1997;29:1133–1137.
[CrossRef] [PubMed]Rocchi M, Archidiacono N, Romeo G, Sagiti M, Zardi L. Assignment of the gene for human tenascin to the region q32–q34 of chromosome 9. Hum Genet. 1991;86:612–623.
Gulcher JR, Alexakos MJ, Le-Beau MM, Lemons RS, Stefansson K. Chromosomal localisation of the human hexabranchion (tenascin) gene and evidence for recent reduplication within the gene. Genomics
. 1990;6:616–622.
[CrossRef] [PubMed]Jones FS, Hoffman S, Cunningham BA, Edelman GM. A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions. Proc Natl Acad Sci USA
. 1989;86:1905–1909.
[CrossRef] [PubMed]Chiquet–Eherismann R, Matsuoka Y, Hofer U, Spring J, Bernasconi C, Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Reg. 1991;2:927–938.
Siri A, Carnemolla B, Saginati M, et al. Human tenascin: primary structure, pre-mRNA splicing patterns and localisation of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Res
. 1991;19:525–531.
[CrossRef] [PubMed]Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res
. 1993;21:163–168.
[CrossRef] [PubMed]Borsi L, Balza E, Castellani P, et al. Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun
. 1994;1:307–317.
[CrossRef] [PubMed]Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer
. 1997;72:236–240.
[CrossRef] [PubMed]Saghizadeh M, Khin HL, Bourdon M, Kenney MC, Ljubimov AV. Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas. Cornea
. 1998;17:326–332.
[CrossRef] [PubMed]Ljubimov AV, Saghizadeh M, Spirin KS, et al. Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci
. 1998;39:1135–1142.
[PubMed]Spring J, Beck K, Chiquet–Eherismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989;59:3253–3234.
Prieto AL, Andersson–Fisone C, Crossin KL. Characterisation of multiple adhesive and counter adhesive domains in the extracellular matrix protein cytotactin. J Cell Biol
. 1992;119:663–678.
[CrossRef] [PubMed]Husmann K, Faissner A, Schachner M. Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J Cell Biol
. 1992;116:1475–1486.
[CrossRef] [PubMed]Hoffman S, Dutton SL, Ernst H, et al. Functional characterisation of antiadhesion molecules. Perspect Dev Neurobiol
. 1994;2:101–110.
[PubMed]Tremble P, Chiquet–Eherismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell
. 1994;5:439–453.
[CrossRef] [PubMed]Dörries U, Taylor J, Xiao Z, Lochter A, Montag D, Schachner M. Distinct effects of recombinant tenascin-C domains on neuronal cell adhesion, growth cone guidance, and neuronal polarity. J Neurosci Res
. 1996;43:420–438.
[CrossRef] [PubMed]Götz B, Scholze A, Clement A, et al. Tenascin-C contains distinct adhesive, antiadhesive, and neurite outgrowth sites for neurons. J Cell Biol
. 1996;132:681–699.
[CrossRef] [PubMed]Scholze A, Götz B, Faissner A. Glial cell interactions with tenascin-C: adhesion and repulsion to different tenascin-C domains is cell type related. Int J Dev Neurosci
. 1996;14:315–329.
[CrossRef] [PubMed]Fischer D, Brown–Ludi M, Schultheness T, Chiquet–Eherismann R. Concerted action of tenascin-C domains in cell adhesion and promotion of neurite outgrowth. J Cell Sci
. 1997;110:1513–1522.
[PubMed]Lochter A, Schachner M. Tenascin and extracellular matrix glycoproteins: from promotion to polarization of neurite growth in vitro. J Neurosci
. 1993;13:3986–4000.
[PubMed]Maseruka H, Bonshek RE, Tullo AB. Tenascin-C expression in normal, inflamed and scarred human corneas. Br J Ophthalmol
. 1997;81:677–682.
[CrossRef] [PubMed]Maseruka H, Ataullah SM, Zardi L, Tullo AB, Ridgway AEA, Bonshek RE. Tenascin-cytotactin (TN-C) variants in pseudophakic/aphakic bullous keratopathy corneas. Eye
. 1998;12:729–734.
[CrossRef] [PubMed]Bonshek RE, Ridgway AEA, Tullo AB, Zardi L, Maseruka H. The time course and patterns of expression of tenascin-C (TN-C) variants in human corneal wound healing [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1999;40(4)S336.Abstract nr 1780
Tervo T, van Setten GB, Lehto I, Tervo K, Tarkkanen A, Virtanen I. Immunohistochemical demonstration of tenascin in the normal human limbus with special reference to trabeculectomy. Ophthalmic Res
. 1990;22:128–133.
[CrossRef] [PubMed]Uusitalo M. Immunohistochemical localisation of chondroitin sulphate proteoglycan and tenascin in the human eye compared with HNK-1 epitope. Graefes Arch Clin Exp Ophthalmol
. 1994;232:657–665.
[CrossRef] [PubMed]Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci
. 1996;37:997–1007.
[PubMed]Tuori AJ, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol
. 1997;235:222–229.
[CrossRef] [PubMed]Maguen E, Alba SS, Burgeson RE, et al. Alterations of corneal extracellular matrix after multiple refractive procedures: a clinical and immunohistochemical study. Cornea
. 1997;16:675–682.
[PubMed]Balza E, Siri A, Ponassi M, et al. Production and characterisation of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett
. 1993;332:39–43.
[CrossRef] [PubMed]Carnemolla B, Castellani P, Ponassi M, et al. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol
. 1999;154:1345–1352.
[CrossRef] [PubMed]Kaplony YL, Zimmermann DR, Fischer RW, et al. Tenascin Mr 220,000 isoform expression correlates with corneal migration. Development
. 1991;112:605–614.
[PubMed]Tucker RP. The in situ localisation of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development
. 1993;117:347–358.
[PubMed]Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci
. 1999;40:1071–1080.
[PubMed]Tervo K, van Setten GB, Beuerman RW, Virtanen I, Tarkkanen A, Tervo T. Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy: immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci
. 1991;32:2912–2918.
[PubMed]van Setten GB, Koch JW, Tervo K, et al. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser surgery. Graefes Arch Clin Exp Ophthalmol
. 1992;230:178–183.
[CrossRef] [PubMed]Latvala T, Tervo K, Mustonen R, Tervo T. Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study. Br J Ophthalmol
. 1995;79:65–69.
[CrossRef] [PubMed]Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation: tryptase is a novel, potent angiogenic factor. J Clin Invest
. 1997;99:2691–2700.
[CrossRef] [PubMed]Castellucci M, Classen–Linke I, Muhlhauser J, Kaufmann P, Zardi L, Chiquet–Eherismann R. The human placenta: a model for tenascin expression. Histochemistry
. 1991;95:449–458.
[CrossRef] [PubMed]Yamanaka M, Taga M, Minaguchi H. Immunohistological localisation of tenascin in the human endometrium. Gynecol Obstet Invest
. 1996;41:247–252.
[CrossRef] [PubMed]Kruse FE, Völcker HE. Stem cells, wound healing, growth factors, and angiogenesis. Curr Opin Ophthalmol
. 1997;8:46–54.
[CrossRef] Borsi L, Balza E, Castellani P, et al. Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun
. 1994;1:307–317.
[CrossRef] [PubMed]